Biological Sciences Division
Published September 9, 2021 | Version v1
Patent Open

COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH

Creators

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Provided herein are compositions comprising Sel1-derived peptides thereof, and method of use thereof for the treatment/prevention excess oxalate levels and conditions and diseases related thereto. In particular, peptides comprise Sel-like repeat (SLR) domains and/or tetratricopeptide (TPR) domains and may be linked together or with other peptides or polypeptides to treat/prevent diseases/conditions related to excess oxalate levels, such as hyperoxaluria and/or hyperoxalemia.

Files

US20210275629.pdf

Files (1.7 MB)

Name Size Download all
md5:0104ef2779fa868bb6fcb49c496436b6
1.7 MB Preview Download

Additional details

Identifiers

Patent application number
US 201917260690 A
Patent number
US 2021/0275629 A1
Other
oai:uchicago.tind.io:8902

Dates

Patent filed
2019-07-18

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine, Microbiology